Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827–34.
Organization WH. Medication Without Harm—WHO Global Patient Safety Challenge. In: Organization WH, editor. Geneva: World Health Organization 2017.
Sutherland JJ, Daly TM, Liu X, Goldstein K, Johnston JA, Ryan TP. Co-prescription trends in a large cohort of subjects predict substantial drug-drug interactions. PLoS ONE. 2015;10(3): e0118991.
Article PubMed PubMed Central Google Scholar
Quinn KJ, Shah NH. A dataset quantifying polypharmacy in the United States. Sci Data. 2017;31(4): 170167.
Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016;82(3):583–623.
Article PubMed PubMed Central Google Scholar
Woodford HJ, Fisher J. New horizons in deprescribing for older people. Age Ageing. 2019;48(6):768–75.
Fried TR, O’Leary J, Towle V, Goldstein MK, Trentalange M, Martin DK. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014;62(12):2261–72.
Article PubMed PubMed Central Google Scholar
National Center for Injury Prevention and Control. Web-based Injury Statistics Query and Reporting System [cited; Available from:
Bergen G, Stevens M, Burns E. Falls and fall injuries among adults aged ≥ 65 years- United States, 2014. Weekly. 2016;65(37):993–8.
Stenhagen M, Ekstrom H, Nordell E, Elmstahl S. Accidental falls, health-related quality of life and life satisfaction: a prospective study of the general elderly population. Arch Gerontol Geriatr. 2014;58(1):95–100.
Freeland KN, Thompson AN, Zhao Y, Leal JE, Mauldin PD, Moran WP. Medication use and associated risk of falling in a geriatric outpatient population. Ann Pharmacother. 2012;46(9):1188–92.
Glass J, Lanctôt KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005;331(7526):1169.
Article PubMed PubMed Central Google Scholar
Kaufmann CN, Spira AP, Alexander GC, Rutkow L, Mojtabai R. Emergency department visits involving benzodiazepines and non-benzodiazepine receptor agonists. Am J Emerg Med. 2017;35(10):1414–9.
Article PubMed PubMed Central Google Scholar
Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert AS. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ. 2015;350: h2698.
Article PubMed PubMed Central Google Scholar
Edinoff AN, Nix CA, Hollier J, Sagrera CE, Delacroix BM, Abubakar T, Cornett EM, Kaye AM, Kaye AD. Benzodiazepines: uses, dangers, and clinical considerations. Neurol Int. 2021;13(4):594–607.
Article CAS PubMed PubMed Central Google Scholar
Brandt J, Janzen D, Alessi-Severini S, Singer A, Chateau D, Enns M, Leong C. Risk of long-term benzodiazepine and Z-drug use following the first prescription among community-dwelling adults with anxiety/mood and sleep disorders: a retrospective cohort study. BMJ Open. 2021;11(11): e046916.
Article PubMed PubMed Central Google Scholar
Brandt J, Bressi J, Le ML, et al. Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review. eClinicalMedicine. 2024;70:1–16.
Borda MG, Jaramillo-Jimenez A, Oesterhus R, Santacruz JM, Tovar-Rios DA, Soennesyn H, Cano-Gutierrez CA, Vik-Mo AO, Aarsland D. Benzodiazepines and antidepressants: effects on cognitive and functional decline in Alzheimer’s disease and Lewy body dementia. Int J Geriatr Psychiatry. 2021;36(6):917–25.
Díaz-Gutiérrez MJ, Martínez-Cengotitabengoa M, Sáez de Adana E, Cano AI, Martínez-Cengotitabengoa MT, Besga A, Segarra R, González-Pinto A. Relationship between the use of benzodiazepines and falls in older adults: a systematic review. Maturitas. 2017;101:17–22.
Donnelly K, Bracchi R, Hewitt J, Routledge PA, Carter B. Benzodiazepines, Z-drugs and the risk of hip fracture: a systematic review and meta-analysis. PLoS ONE. 2017;12(4): e0174730.
Article PubMed PubMed Central Google Scholar
Park SM, Ryu J, Lee DR, Shin D, Yun JM, Lee J. Zolpidem use and risk of fractures: a systematic review and meta-analysis. Osteoporos Int. 2016;27(10):2935–44.
Article CAS PubMed Google Scholar
Brandt J, Leong C. Benzodiazepines and Z-Drugs: an updated review of major adverse outcomes reported on in epidemiologic research. Drugs R D. 2017;17(4):493–507.
Article PubMed PubMed Central Google Scholar
Schifano F, Chiappini S, Corkery JM, Guirguis A. An insight into Z-drug abuse and dependence: an examination of reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions. Int J Neuropsychopharmacol. 2019;22(4):270–7.
Article CAS PubMed PubMed Central Google Scholar
Capiau A, Huys L, van Poelgeest E, van der Velde N, Petrovic M, Somers A. Therapeutic dilemmas with benzodiazepines and Z-drugs: insomnia and anxiety disorders versus increased fall risk: a clinical review. Eur Geriatr Med. 2023;14(4):697–708.
Lee J, Negm A, Peters R, Wong EKC, Holbrook A. Deprescribing fall-risk increasing drugs (FRIDs) for the prevention of falls and fall-related complications: a systematic review and meta-analysis. BMJ Open. 2021;11(2): e035978.
Article PubMed PubMed Central Google Scholar
Ibrahim K, Cox NJ, Stevenson JM, Lim S, Fraser SDS, Roberts HC. A systematic review of the evidence for deprescribing interventions among older people living with frailty. BMC Geriatr. 2021;21(1):258.
Article PubMed PubMed Central Google Scholar
Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging de fi nition of “deprescribing” with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254–68.
Article PubMed PubMed Central Google Scholar
Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296(21):2563–71.
Article CAS PubMed Google Scholar
Nguyen T, Dublin S, Albertson-Junkans L, et al. Defining key deprescribing measures from electronic health data: Learnings from a multisite data harmonization project. Pharmacoepidemiol Drug Saf. 2023;32:336–7.
Martin P, Tamblyn R, Benedetti A, Ahmed S, Tannenbaum C. Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE Randomized Clinical Trial. JAMA. 2018;320(18):1889–98.
Article PubMed PubMed Central Google Scholar
Von Korff M, Saunders K, Dublin S, Walker RL, Thakral M, Sherman KJ, Ludman EJ, Hansen RN, Parchman M, Shortreed SM. Impact of chronic opioid therapy risk reduction initiatives on opioid overdose. J Pain. 2019;20(1):108–17.
Dublin S, Walker RL, Shortreed SM, Ludman EJ, Sherman KJ, Hansen RN, Thakral M, Saunders K, Parchman ML, Von Korff M. Impact of initiatives to reduce prescription opioid risks on medically attended injuries in people using chronic opioid therapy. Pharmacoepidemiol Drug Saf. 2019;28(1):90–6.
Von Korff M, Dublin S, Walker RL, Parchman M, Shortreed SM, Hansen RN, Saunders K. The impact of opioid risk reduction initiatives on high-dose opioid prescribing for patients on chronic opioid therapy. J Pain. 2016;17(1):101–10.
Ho AM, Dion PW, Ng CS, Karmakar MK. Understanding immortal time bias in observational cohort studies. Anaesthesia. 2013;68(2):126–30.
Elias AM, Ogunwale AN, Pepin MJ, Bailey JC, Adams AD, Colon-Emeric CS, et al. High prevalence of fall-related medication use in older veterans at risk for falls. J Am Geriatr Soc. 2020;68(2):438–9.
Comments (0)